Ashford Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ligand Pharmaceuticals
LGND
|
+$14.5M |
| 2 |
Globalstar
GSAT
|
+$10.7M |
| 3 |
Meta Platforms (Facebook)
META
|
+$3.6M |
| 4 |
Cellebrite
CLBT
|
+$3.57M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$2.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Twilio
TWLO
|
+$13.4M |
| 2 |
Viasat
VSAT
|
+$11.8M |
| 3 |
CSGS
CSG Systems International
CSGS
|
+$9.54M |
| 4 |
CYBR
CyberArk
CYBR
|
+$6.37M |
| 5 |
AXON
Axon Enterprise
AXON
|
+$5.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.08% |
| 2 | Financials | 17.53% |
| 3 | Technology | 17.22% |
| 4 | Industrials | 12.01% |
| 5 | Communication Services | 6.95% |
Similar funds
Ashford Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Ashford Capital Management held 98 positions worth $739M, down 0.96% from $746M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Ashford Capital Management withdrew a net $43.7M in Q1 2024, closing 7 positions and reducing 48 holdings. Its most notable exit was Twilio, an estimated $13.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Financials and Technology.
Against the trend, Ashford Capital Management opened a new position in Ligand Pharmaceuticals worth $14.4M.
- Ashford Capital Management's largest Q1 2024 buy was Ligand Pharmaceuticals: 196,535 shares worth $14.4M.
- Ashford Capital Management added most to Globalstar in Q1 2024, an estimated $10.7M increase.
- Ashford Capital Management's biggest Q1 2024 reduction was Viasat, cutting an estimated $11.8M.
- Ashford Capital Management fully exited Twilio in Q1 2024, selling an estimated $13.4M.
- Ashford Capital Management's ten largest holdings make up 38% of its $739M portfolio in Q1 2024.
- Ashford Capital Management opened 5 new positions and closed 7 in Q1 2024.
- Ashford Capital Management's portfolio value fell 0.96% quarter-over-quarter to $739M.
Based on Ashford Capital Management's 13F filing for Q1 2024, filed 15 May 2024.